Hydrofarm Holdings Group, Inc. — Q3 2021 Form 10-Q
Reporting period: Three and nine months ended September 30, 2021. Hydrofarm distributes and manufactures controlled-environment agriculture equipment and supplies, primarily in the U.S. and Canada. Financial amounts below are in U.S. dollars; millions are rounded.
Financial performance
| Metric | Q3 2021 | Q3 2020 | Nine months 2021 | Nine months 2020 |
|---|---|---|---|---|
| Net sales | $123.8m | $96.7m | $369.0m | $254.8m |
| Gross profit / margin | $30.0m / 24.2% | $18.2m / 18.8% | $82.8m / 22.4% | $47.6m / 18.7% |
| Operating income (loss) | ($2.4m) | $5.5m | $6.3m | $10.3m |
| Net income | $17.3m | $2.7m | $24.5m | $2.1m |
| Adjusted EBITDA (non-GAAP) | $16.1m | $7.4m | $42.2m | $16.1m |
| Adjusted EBITDA margin (non-GAAP) | 13.0% | 7.7% | 11.4% | 6.3% |
Q3 sales increased 28.1%; management attributed the increase to 24.4% higher product volume overall, 2.8% from price and mix, and 0.8% from foreign exchange. Within volume, organic sales fell 7.7%, while recently acquired proprietary brands contributed 32.1% growth. Nine-month sales rose 44.8%, with volume up 39.3% (organic sales up 23.6% and acquired brands contributing 15.7%), price and mix up 3.7%, and foreign exchange up 1.9%.
Gross margin improved substantially, primarily on a richer mix of higher-margin proprietary and preferred brands; nine-month results also benefited from improved first-half labor efficiencies. These gains more than offset higher freight/import and labor costs. Q3 operating loss reflected SG&A growth, including acquisition-related and integration costs, public-company and growth-related expenses, and warrant solicitation fees. The reported Q3 and nine-month net income included income-tax benefits of $19.8m and $19.0m, respectively, primarily from releasing part of the deferred-tax valuation allowance following the H&G acquisition. Thus, net income growth should be viewed in light of this tax benefit.
Cash flow, liquidity and debt
- For the first nine months, operating cash flow was negative $17.5m, versus negative $7.8m a year earlier. Management cited a $39.8m increase in working capital, including substantial inventory growth.
- Investing cash outflow was $419.4m, principally $415.9m for four acquisitions; financing cash inflow was $374.4m, including $309.8m net proceeds from a May follow-on offering and $56.8m from warrant exercises.
- Cash, cash equivalents and restricted cash totaled $14.5m at September 30, 2021, down from $77.0m at December 31, 2020. Current assets were $222.5m and current liabilities were $118.6m.
- Debt at September 30 was $27.7m, including $26.5m drawn on the JPMorgan revolver. The $100m revolver had approximately $78.6m of borrowing availability, including $51.8m unused; the company reported compliance with its covenants, including a 1.1x minimum fixed-charge coverage ratio.
- After quarter-end, the company borrowed $125m under a senior secured term loan, receiving estimated net proceeds of $119.2m. It matures in October 2028, carries interest at LIBOR plus 5.50% (subject to a 1.0% floor) or an alternative base rate plus 4.50%, and was intended to fund the subsequent IGE acquisition and general corporate purposes.
Material changes, outlook and risks
- During the period, Hydrofarm acquired Heavy 16, the House & Garden entities, Aurora and Greenstar, broadening proprietary nutrients, fertilizers and grow-media brands. The acquisitions added $297.5m of goodwill and contributed an estimated $31m of Q3 sales and $9m of Q3 net income since acquisition dates; management cautioned these contribution estimates are approximate. Purchase-price allocations remained provisional.
- On November 1, 2021, the company acquired the IGE entities, a manufacturer of horticulture benches, racking and LED lighting systems, for approximately $58m, subject to customary adjustments. This is a subsequent event, not included in September 30 results.
- No specific revenue or earnings guidance is provided in the filing. Management described the business as resilient during COVID-19 but reported supply-chain interruptions and higher shipping costs; it warned renewed factory closures or cost increases could affect inventory availability and margins. Management also cited short-term oversupply pressuring cannabis-growing activity, particularly in California and Canada.
- Other relevant exposures include acquisition integration and execution, contingent acquisition consideration, competition and customer/grower conditions, foreign-exchange movements, and substantial new warehouse lease commitments. Executed but not-yet-commenced leases had $53.8m of future minimum payments disclosed; additional warehouse leases were signed after quarter-end.
- Management concluded disclosure controls were not effective as of September 30 because previously disclosed material weaknesses in internal control over financial reporting had not been remediated. Remediation efforts were ongoing; the company warned it could not assure they would be sufficient.
Most important facts for investors to verify
- Whether organic demand stabilizes after Q3’s 7.7% decline, and how much future growth depends on acquired brands and acquisitions.
- Whether the improved gross margin persists as freight, import, labor and supply-chain costs evolve.
- How much reported earnings reflect the nonrecurring tax benefit, acquisition costs, and other Adjusted EBITDA exclusions; compare non-GAAP results with GAAP cash generation.
- Whether working-capital investment, particularly inventory, converts into sales and operating cash flow, given low period-end cash after acquisitions.
- Integration results and final purchase accounting for the acquisitions, contingent consideration, and the financing and performance of the post-quarter IGE acquisition.
- Progress in remediating material weaknesses and continued compliance with debt covenants and lease obligations.